Your browser doesn't support javascript.
loading
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.
de Las Heras, Begoña; Saini, Kamal S; Boyle, Frances; Ades, Felipe; de Azambuja, Evandro; Bozovic-Spasojevic, Ivana; Romano, Marco; Capelan, Marta; Prasad, Rajeev; Pattu, Pugazhenthi; Massard, Christophe; Portera, Chia; Saini, Monika Lamba; Singh, Brajendra Prasad; Venkitaraman, Ramachandran; McNally, Richard; Leone, Manuela; Grande, Enrique; Gupta, Sudeep.
Afiliación
  • de Las Heras B; Covance Inc., Princeton, NJ, USA.
  • Saini KS; Madrid Medical Doctors Association, Madrid, Spain.
  • Boyle F; Covance Inc., Princeton, NJ, USA. kamalveer.saini@covance.com.
  • Ades F; East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK. kamalveer.saini@covance.com.
  • de Azambuja E; Mater Hospital, Sydney, Australia.
  • Bozovic-Spasojevic I; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Romano M; Institut Jules Bordet, Brussels, Belgium.
  • Capelan M; Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Prasad R; Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Pattu P; Covance Inc., Princeton, NJ, USA.
  • Massard C; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Portera C; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK.
  • Saini ML; East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.
  • Singh BP; Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Venkitaraman R; Covance Inc., Princeton, NJ, USA.
  • McNally R; HistoGeneX, Antwerp, Belgium.
  • Leone M; Max Smart Super Speciality Hospital, Saket, New Delhi, India.
  • Grande E; East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.
  • Gupta S; Covance Inc., Princeton, NJ, USA.
Oncol Ther ; 8(2): 171-182, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32749634
The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda